The estimated Net Worth of David A Wilson is at least $33.9 millió dollars as of 17 September 2021. Mr. Wilson owns over 36,052 units of Cencora stock worth over $33,178,989 and over the last 18 years he sold COR stock worth over $398,014. In addition, he makes $302,305 as Lead Independent Director at Cencora.
David has made over 4 trades of the Cencora stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 36,052 units of COR stock worth $398,014 on 17 September 2021.
The largest trade he's ever made was selling 36,052 units of Cencora stock on 17 September 2021 worth over $398,014. On average, David trades about 530 units every 16 days since 2007. As of 17 September 2021 he still owns at least 140,458 units of Cencora stock.
You can see the complete history of Mr. Wilson stock trades at the bottom of the page.
Dr. David A. Wilson serves as Lead Independent Director of the Company. Mr. Wilson has served as a director since September 2010. Mr. Wilson served as President and Chief Executive Officer of the Graduate Management Admission Council (the "Council") from 1995 until his retirement in December 2013. The Council is the owner of the Graduate Management Admission Test, the GMAT. Prior to 1995, he was a Managing Partner and National Director for Professional Development at Ernst & Young LLP, a public accounting firm. From 1968 to 1978, Mr. Wilson held faculty positions at the University of Texas at Austin, where he was awarded tenure, and at Harvard Business School. Mr. Wilson completed his undergraduate studies at Queen's University in Canada, received his M.B.A. at the University of California, Berkeley, and received his doctorate at the University of Illinois. He is a Chartered Accountant in Canada and a Certified Public Accountant in the United States. Mr. Wilson served on the board of directors of Laureate Education, Inc. ("Laureate"), a company which provides access to high-quality, innovative institutions of higher education, from 2002 to 2007, and of Terra Industries, Inc. ("Terra"), a producer and marketer of nitrogen products for the agricultural and industrial markets, from 2009 to 2010. At Laureate, he chaired the Audit Committee and served as a member of the Nominating and Governance Committee and the Conflicts Committee. He served on the Audit Committee of Terra. He has served on the Worldwide Board of Junior Achievement, the Conseil d'Administration de la Confrérie de la Chaîne des Rôtisseurs (Paris) and The Wolf Trap Foundation. Mr. Wilson served on the board of directors of Barnes and Noble, Inc., a book retailer and content, commerce and technology company, and as chair of its Audit Committee from September 2010 to August 2015, and currently serves on the board of directors of Barnes & Noble Education, Inc., a provider of educational services, and as chair of its Audit Committee.
As the Lead Independent Director of Cencora, the total compensation of David Wilson at Cencora is $302,305. There are 5 executives at Cencora getting paid more, with Paul Szurek having the highest compensation of $5,385,070.
David Wilson is 79, he's been the Lead Independent Director of Cencora since 2016. There are no older and 14 younger executives at Cencora.
David's mailing address filed with the SEC is C/O CORESITE REALTY CORPORATION, 1001 17TH STREET, SUITE 500, DENVER, CO, 80202.
Over the last 14 years, insiders at Cencora have traded over $67,682,023 worth of Cencora stock and bought 34,206 units worth $1,080,918 . The most active insiders traders include Realty Iii, Gp, L.L.C.Carly..., Iv Aiv Gp, L.L.C.Crp Iv Aiv... és Group Management L.L.C.Carl.... On average, Cencora executives and independent directors trade stock every 13 days with the average trade being worth of $18,365,869. The most recent stock trade was executed by Brian Warren on 5 November 2021, trading 850 units of COR stock currently worth $130,577.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Cencora executives and other stock owners filed with the SEC include: